CASP14 polyclonal antibody

Catalog # PAB0250

Size

Price

Stock

Quantity

Size:50 uL
Price: USD $ 428.00
Stock:
order now, ship in 5 days
abnova-minus
abnova-plus

* The price is valid only in USA. Please select country.

Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
Images
Western Blot (Tissue lysate)
Application

Western Blot (Tissue lysate)

Western blot analysis of CASP14. Tissue lysates (50 ug/lane) and recombinant human CASP14 were (Hu C14, 15 ng) were western blotted with CASP14 polyclonal antibody (Cat # PAB0250) at 1 : 2000. The antisera detected both the proform of CASP14, and the large and small subunits of active/cleaved CASP14.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Application

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)

Formalin-fixed paraffin-embedded sections from a human ovarian cancer tissue microarray stained for CASP14 expression. Using CASP14 polyclonal antibody (Cat # PAB0250) at 1 : 2000. Low (A) and high (B) stage ovarian tumor tissue cores. High magnification from areas of the tissue cores (A1 and B1) . Decreased CASP14 expression was seen in the high grade, compared to the low grade tumor. Hematoxylin-eosin counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Application

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)

Formalin-fixed paraffin-embedded tissue sections of human cervix stained for CASP14 expression. Using CASP14 polyclonal antibody (Cat # PAB0250) at 1 : 2000. A. Normal cervix (squamous epithelium) . B. CIN1 (low-grade squamous intraepithelial lesion, mild dysplasia) . C. CIN2 (high-grade squamous intraepithelial lesion, moderate dysplasia) . D. CIN3 (high-grade squamous intraepithelial lesion ; severe dysplasia-carcinoma in situ) . In normal cervi, CASP14 staining was found most in the midzone layer, but was absent from the basal/parabasal cell layer where mitotically active cells are known to reside. This suggests induction of CASP14 expression with differentiation. CASP14 expression declined progressively during malignant transformation as the histologic severity of the cervical atypia advanced from CIN1 to CIN3. Hematoxylin-eosin counterstain.

  • Specification

    Product Description

    Rabbit polyclonal antibody raised against full length recombinant CASP14.

    Immunogen

    Recombinant protein corresponding to full length human CASP14.

    Host

    Rabbit

    Reactivity

    Dog, Gerbils, Human, Mouse, Rat

    Form

    Liquid

    Recommend Usage

    The optimal working dilution should be determined by the end user.

    Storage Buffer

    In serum (0.05% sodium azide)

    Storage Instruction

    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.

    Note

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

  • Applications

    Western Blot (Tissue lysate)

    Western blot analysis of CASP14. Tissue lysates (50 ug/lane) and recombinant human CASP14 were (Hu C14, 15 ng) were western blotted with CASP14 polyclonal antibody (Cat # PAB0250) at 1 : 2000. The antisera detected both the proform of CASP14, and the large and small subunits of active/cleaved CASP14.

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)

    Formalin-fixed paraffin-embedded sections from a human ovarian cancer tissue microarray stained for CASP14 expression. Using CASP14 polyclonal antibody (Cat # PAB0250) at 1 : 2000. Low (A) and high (B) stage ovarian tumor tissue cores. High magnification from areas of the tissue cores (A1 and B1) . Decreased CASP14 expression was seen in the high grade, compared to the low grade tumor. Hematoxylin-eosin counterstain.

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)

    Formalin-fixed paraffin-embedded tissue sections of human cervix stained for CASP14 expression. Using CASP14 polyclonal antibody (Cat # PAB0250) at 1 : 2000. A. Normal cervix (squamous epithelium) . B. CIN1 (low-grade squamous intraepithelial lesion, mild dysplasia) . C. CIN2 (high-grade squamous intraepithelial lesion, moderate dysplasia) . D. CIN3 (high-grade squamous intraepithelial lesion ; severe dysplasia-carcinoma in situ) . In normal cervi, CASP14 staining was found most in the midzone layer, but was absent from the basal/parabasal cell layer where mitotically active cells are known to reside. This suggests induction of CASP14 expression with differentiation. CASP14 expression declined progressively during malignant transformation as the histologic severity of the cervical atypia advanced from CIN1 to CIN3. Hematoxylin-eosin counterstain.

    Immunoprecipitation

  • Gene Info — CASP14

    Entrez GeneID

    23581

    Gene Name

    CASP14

    Gene Alias

    MGC119078, MGC119079

    Gene Description

    caspase 14, apoptosis-related cysteine peptidase

    Omim ID

    605848

    Gene Ontology

    Hyperlink

    Gene Summary

    This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. [provided by RefSeq

    Other Designations

    apoptosis-related cysteine protease|caspase 14|caspase 14, apoptosis-related cysteine protease

  • Interactome
  • Disease
  • Publication Reference
Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
4 Products to Compare
Remove All